Oddifact
Oddifact uses AI to accelerate rare-disease drug development and secure orphan drug designations. Its SAVE platform analyzes academic research and repurposes existing drugs to create new therapies. The company employs retrieval-augmented generation and other AI methods to transform clinical data into actionable assets for regulators and manufacturers. Business model centers on licensing and collaboration with pharmaceutical manufacturers and laboratories. With a global reach across North America and Europe, Oddifact aims to speed therapies to patients and expand its pipeline.
Oddifact
Oddifact uses AI to accelerate rare-disease drug development and secure orphan drug designations. Its SAVE platform analyzes academic research and repurposes existing drugs to create new therapies. The company employs retrieval-augmented generation and other AI methods to transform clinical data into actionable assets for regulators and manufacturers. Business model centers on licensing and collaboration with pharmaceutical manufacturers and laboratories. With a global reach across North America and Europe, Oddifact aims to speed therapies to patients and expand its pipeline.